title: Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings.
abstract: OBJECTIVE
  To report on the use of trypan blue (TB) 0.06% for staining the internal limiting membrane (ILM) and epiretinal membrane (ERM) during vitrectomy and report on their histology.
  
  
  METHODS
  14 consecutive patients with idiopathic macular hole or macular pucker (seven patients each) were prospectively recruited for ILM or ERM peel respectively. After pars plana vitrectomy and induction of posterior vitreous detachment, 0.5 ml TB 0.06% in phosphate buffered saline (VisonBlue) was injected over the posterior pole in an air filled eye and left for 2 minutes. The stained tissue was peeled with intraocular forceps. Specimens were evaluated using histochemical and immunohistochemical methods.
  
  
  RESULTS
  The average follow up was 4.4 months. Internal limiting membranes and epiretinal membranes were stained satisfactorily in all cases and removed successfully. Eight patients (57%) had improvement of 2 or more Snellen lines. All seven macular holes closed. In the ERM cases, no residual membranes were observed clinically, at the latest follow up. No complications relating to the use of the dye were encountered intraoperatively or postoperatively. Of the 14 procedures, nine (four macular hole and five macular pucker) yielded sufficient tissue for histopathological evaluation. Histological and immunohistological assessment revealed that the morphology of these specimens was similar to that observed in macular hole ILM and macular pucker ERM removed without the aid of dye.
  
  
  CONCLUSIONS
  TB staining facilitated the identification and delineation of ILM and ERM removal during the surgical management of macular holes and macular pucker. The visual outcome of this series and the specimens removed suggest they are no different from those without TB staining. Its use in posterior segment appears to be safe but further studies are required to investigate its long term safety.
authors.affiliation: St Paul's Eye Unit, Royal Liverpool University Hospital, UK. ken@liteapot.freewire.co.uk
authors.forename: K
authors.initials: K
authors.lastname: Li
authors.forename: D
authors.initials: D
authors.lastname: Wong
authors.forename: P
authors.initials: P
authors.lastname: Hiscott
authors.forename: P
authors.initials: P
authors.lastname: Stanga
authors.forename: C
authors.initials: C
authors.lastname: Groenewald
authors.forename: J
authors.initials: J
authors.lastname: McGalliard
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008266:Macula Lutea / Q000473:pathology / Q000601:surgery*; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D011446:Prospective Studies; D012167:Retinal Perforations / Q000473:pathology / Q000601:surgery*; D016896:Treatment Outcome; D014343:Trypan Blue; D014821:Vitrectomy / Q000379:methods*
chemical_list: D014343:Trypan Blue